Subcapsular hepatic and intraperitoneal bleed after administration of tissue plasminogen activator in a patient with acute myocardial infarction.
Thrombolysis can sometimes cause life-threatening bleeding. In the case reported here, subcapsular hepatic and intraperitoneal bleeding developed after administration of tissue plasminogen activator (tPA) in a patient with acute myocardial infarction. Surgery was required in this patient to stop the bleed.
Ismail
A
A
Long Beach Memorial Heart Institute, Long Beach, California, USA.
Cole
J P
JP
D000368:Aged; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010532:Peritoneal Diseases / Q000139:chemically induced*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator